Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.

News

Blog 2 months ago
Nervonik Expands Leadership Team with Addition of Industry Veterans
Nervonik, Inc., a medical technology company developing a next-generation peripheral nerve stimulation platform for chronic pain, today announced it is expanding its leadership team with the addition of several experienced medical device and neuromodulati
Read more
Report
News newswise.com 3 months ago
Nervonik Announces Completion of Groundbreaking First-in-Human Feasibility Study Demonstrating Nerve Sensing during Peripheral Nerve Stimulation in Multiple Anatomical Targets Newswise
Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the completion of a first-in-human feasibility study demonstrating the ability to record key nerve-related biosig
Read more
Report
Press release PRNewswire 5 months ago
Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy
/PRNewswire/ -- Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today...
Read more
Report
News YahooFinance 1 year ago
Nervonik Successfully Completes Preclinical Testing of Neural Sensing During Peripheral Nerve Stimulation (PNS) in Large Animal Models
Nervonik Inc., a neuromodulation company pioneering advanced Peripheral Nerve Stimulation (PNS) technologies, announced today that it has successfully completed key milestones in preclinical testing of its proprietary ECAP (Evoked Compound Action Potentia
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Financials

Total raised
$65.5M
Latest round
Series B
Funding rounds
2
Funding rounds
Round Announced Amount
Series B 2026 $52.5M Details
Series A 2025 $13M Details